You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel backs Pfizer's COVID-19 vaccine for kids

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. The FDA panel voted that the vaccine's benefits outweigh risks. (Oct. 26)
image beaconimage beaconimage beacon